Showing results (1601-1610 of 1,735) with videos related to

Sort By:
Pageof 174
Investigational New Drugs|June 19, 2015
Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)B B Y Ma, B C Goh, W T Lim, et al.
Pathogens (Basel, Switzerland)|October 27, 2022
Habitat and Season Drive Chigger Mite Diversity and Abundance on Small Mammals in Peninsular MalaysiaHadil Alkathiry, Ahmed Al-Rofaai, Zubaidah Ya'cob, et al.
Blood|January 24, 2015
Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphomaYun-Wen Chen, Tianhuan Guo, Lijun Shen, et al.
The Lancet Regional Health. Europe|May 15, 2024
Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort studyIsaac Allen, Hend Hassan, Walburga Yvonne Joko-Fru, et al.
Cardio-Oncology (London, England)|March 15, 2022
Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational studyYouquan Li, Whee Sze Ong, Ma Than Than Shwe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 22, 2019
Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B StudyEnriqueta Felip, Filippo G de Braud, Michela Maur, et al.
The Lancet. Oncology|May 10, 2025
Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health recordsHend Hassan, Isaac Allen, Tameera Rahman, et al.
Oncogene|September 1, 1999
Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancerU S Khoo, H Ozcelik, A N Cheung, et al.
Leukemia|November 6, 2010
Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitroJ Iqbal, D D Weisenburger, A Chowdhury, et al.
Cancer Science|January 4, 2021
The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma ConsortiumTom Wei-Wu Chen, Angela Pang, Mark E Puhaindran, et al.
Pageof 174